Virpax Pharmaceuticals Inc logo

Virpax Pharmaceuticals Inc Share Price (NASDAQ: VRPX)

$0.02

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 3 Apr 2025

Check the interactive Virpax Pharmaceuticals Inc Stock chart to analyse performance

Virpax Pharmaceuticals Inc Key Stats

Check Virpax Pharmaceuticals Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.02
Open
$0.2
Market Capitalization
$3.0M
Today's Volume
$148.8K
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-13.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-362.29%

Global Institutional Holdings in Virpax Pharmaceuticals Inc

  • Name

    Holdings %

  • Garden State Investment Advisory Services LLC

    0.22%

  • Geode Capital Management, LLC

    0.16%

  • HRT FINANCIAL LLC

    0.10%

  • Virtu Financial LLC

    0.09%

  • UBS Group AG

    0.05%

  • XTX Topco Ltd

    0.05%

Analyst Recommendation on Virpax Pharmaceuticals Inc Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Virpax Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

About Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also include AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
Organization
Virpax Pharmaceuticals Inc
Employees
2
CEO
Mr. Jatinder Dhaliwal
Industry
Miscellaneous

Key Management of Virpax Pharmaceuticals Inc

NameTitle
Mr. Jatinder Dhaliwal
CEO & Chairman
Mr. Usama Chaudhry
CFO & Corporate Secretary
Dr. Sheila A. Mathias J.D., M.B.A., Ph.D.
Chief Scientific Officer

Important FAQs about investing in VRPX Stock from India :

What is Virpax Pharmaceuticals Inc share price today?

Virpax Pharmaceuticals Inc share price today is $0.02 as on at the close of the market. Virpax Pharmaceuticals Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Virpax Pharmaceuticals Inc share?

Virpax Pharmaceuticals Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Virpax Pharmaceuticals Inc stock price today i.e. is closed at $0.02, lower by 99.98% versus the 52 week high.

How to invest in Virpax Pharmaceuticals Inc Stock (VRPX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Virpax Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Virpax Pharmaceuticals Inc Shares that will get you 75.0000 shares as per Virpax Pharmaceuticals Inc share price of $0.02 per share as on April 3, 2025 at 12:00 am IST.

What is the minimum amount required to buy Virpax Pharmaceuticals Inc Stock (VRPX) from India?

Indian investors can start investing in Virpax Pharmaceuticals Inc (VRPX) shares with as little as ₹88.185 or $1 (as of September 15, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.85 in Virpax Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025). Based on Virpax Pharmaceuticals Inc share’s latest price of $0.02 as on April 3, 2025 at 12:00 am IST, you will get 500.0000 shares of Virpax Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Virpax Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Virpax Pharmaceuticals Inc stock has given 0.0% share price returns and 19.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?